Legal & General Group’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-48
| Closed | -$2K | – | 3568 |
|
|
2022
Q1 | $2K | Hold |
48
| – | – | ﹤0.01% | 3548 |
|
|
2021
Q4 | $3K | Hold |
48
| – | – | ﹤0.01% | 3561 |
|
|
2021
Q3 | $4K | Hold |
48
| – | – | ﹤0.01% | 3483 |
|
|
2021
Q2 | $40K | Buy |
+48
| New | +$40K | ﹤0.01% | 3022 |
|
|
2020
Q2 | – | Sell |
-8
| Closed | -$4K | – | 3426 |
|
|
2020
Q1 | $4K | Sell |
8
-4
| -33% | -$2K | ﹤0.01% | 3283 |
|
|
2019
Q4 | $2K | Buy |
12
+2
| +20% | +$333 | ﹤0.01% | 3362 |
|
|
2019
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 3344 |
|
|
2019
Q2 | $24K | Hold |
10
| – | – | ﹤0.01% | 3124 |
|
|
2019
Q1 | $40K | Buy |
10
+2
| +25% | +$8K | ﹤0.01% | 2789 |
|
|
2018
Q4 | $24K | Hold |
8
| – | – | ﹤0.01% | 3003 |
|
|
2018
Q3 | $45K | Buy |
8
+2
| +33% | +$11.3K | ﹤0.01% | 2824 |
|
|
2018
Q2 | $21K | Sell |
6
-2
| -25% | -$7K | ﹤0.01% | 3171 |
|
|
2018
Q1 | $37K | Hold |
8
| – | – | ﹤0.01% | 2891 |
|
|
2017
Q4 | $32K | Buy |
8
+5
| +167% | +$20K | ﹤0.01% | 3031 |
|
|
2017
Q3 | $16K | Hold |
3
| – | – | ﹤0.01% | 3214 |
|
|
2017
Q2 | $15K | Buy |
+3
| New | +$15K | ﹤0.01% | 3257 |
|